Research and funding lacking for high mortality cancers

The country’s eight most deadly cancers, which are responsible for half of all cancer deaths, receive little attention and significantly less funding than cancers with significantly higher survival rates.

High mortality cancers are defined as those with survival rates of five years or less, and include ovary, brain, myeloma, stomach, esophagus, lung, liver and pancreas.

The way that cancers, including high mortality cancers, are diagnosed and treated may be transformed within 20 years because of advances in human genome research according to the National Cancer Institute. Increasing research and funding for these cancers may be improved by adjusting intellectual property rights between government and private industry, as well as national health privacy rules.

(Sources: Advisory Board Daily Briefing, http://advisoryboard.com, March 25, 2010, CQ HealthBeat, http://cq.com, March 23, 2010)